August 10, 2020, 12.02 AM

WASHINGTON, KOMPAS.com – The $765 million Kodak loan agreement reached with the US government to produce pharmaceutical ingredients has been put on hold.

The temporary halt in the deal was due to “recent allegations of wrongdoing”, according to the US International Development Finance Corp (DFC).

Earlier this week, senior Democratic lawmakers requested that federal regulators investigate securities transactions made by Eastman Kodak Co. and its executives around the time it learned it could receive the government loan.

"Recent allegations of wrongdoing raise serious concerns," DFC said late on Friday in a tweet.

Read also: Kodak Flying High after Striking Manufacturing Deal with US Government

"We will not proceed any further unless these allegations are cleared," the DFC said. It was referring to a letter of interest it signed on July 28 with Kodak.

President Donald Trump on Tuesday said the government would investigate the circumstances surrounding the announcement of the loan, which will help the photographic equipment maker shift into making pharmaceuticals at its US factories.

Kodak shares surged more than 1,000 percent last week after the loan was announced, generating a windfall for executives, some of whom had received options one day earlier.

Lawmakers said they had "serious concerns" about the transactions and asked the Securities and Exchange Commission to investigate the circumstances surrounding the matter.

They cited growing concerns about insider trading.

Page:


Recommendation
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
November 28, 2022, 05.16 PM

Death Toll from Indonesia Quake Rises to 321

News
November 24, 2022, 05.14 PM

Malaysia: Opposition Leader Anwar Ibrahim Named PM

Close Ads